reference/32526418

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32526418

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't\|Validation Study
endingPage	1240
issn	0145-2126
issueIdentifier	9
pageRange	1233-1240
publicationName	Leukemia Research
startingPage	1233
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ff4a24424316d9ba7f18acd9c46af1e4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e56a0721c86d34f4a02694edb55ee01b
bibliographicCitation	de Brito LR, Batey MA, Zhao Y, Squires MS, Maitland H, Leung HY, Hall AG, Jackson G, Newell DR, Irving JA. Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma. Leuk Res. 2011 Sep;35(9):1233–40. doi: 10.1016/j.leukres.2011.01.011. PMID: 21316102.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b51ec43ee80a9ddd27f8d3aba8991bbf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c75996e7006d520318bcdb6474c24b54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f53a32664204329a87db88a204ceee8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93154e722e6a0ef79e76f068df3a4c19 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_572544f9d1b11344fca7734d0a721059 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_606c254d13c6716f7c40f5035fd12beb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff1ef794dc5be67e9c86958a4de78284 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_747b0b346b07db6971f491312843e3aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a197a0d6f38c2bd110eb7d7def6543f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4458ee49103f05cdbff047a18d375428 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3933-3975
date	201109
identifier	https://pubmed.ncbi.nlm.nih.gov/21316102 https://doi.org/10.1016/j.leukres.2011.01.011
isPartOf	https://portal.issn.org/resource/ISSN/0145-2126 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5304
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma
discusses	http://id.nlm.nih.gov/mesh/M0448793 http://id.nlm.nih.gov/mesh/M0016766 http://id.nlm.nih.gov/mesh/M0297822 http://id.nlm.nih.gov/mesh/M0011238 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0358615 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0016885 http://id.nlm.nih.gov/mesh/M0018276 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0328256 http://id.nlm.nih.gov/mesh/M0421253
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009101Q000188 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D020794Q000037
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007211Q000627 http://id.nlm.nih.gov/mesh/D000077210 http://id.nlm.nih.gov/mesh/D010880Q000627 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D009101Q000235 http://id.nlm.nih.gov/mesh/D010793Q000627 http://id.nlm.nih.gov/mesh/D009101Q000473 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D011758Q000627 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D011725Q000627 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D011799Q000627 http://id.nlm.nih.gov/mesh/D004353
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3a236e0877bf928b9d51ea42ef63147c http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cddcd4efec0cdb2be5a641fc4e8ff1c5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_890a7f813cc599a9c308e03a2f2b4ebf http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1401 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151194 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151193 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_086671f4507e548c21ced3a1195e1832 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_106c8f7eb09546f02d46a1d20b67582f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0e74095f48110870967f5317c44ced0a http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247499656 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129776330 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247533733

Total number of triples: 86.